Personal Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$438K Sell
6,474
-814
-11% -$47.7K ﹤0.01% 324
2022
Q3
$363K Buy
7,288
+502
+7% +$26.9K ﹤0.01% 327
2022
Q2
$378K Buy
6,786
+100
+1% +$5.55K ﹤0.01% 304
2022
Q1
$371K Sell
6,686
-1,396
-17% -$71.6K ﹤0.01% 346
2021
Q4
$453K Buy
8,082
+718
+10% +$38.9K ﹤0.01% 353
2021
Q3
$354K Buy
7,364
+248
+3% +$12K ﹤0.01% 367
2021
Q2
$298K Sell
7,116
-1,872
-21% -$72.6K ﹤0.01% 394
2021
Q1
$303K Sell
8,988
-5,202
-37% -$185K ﹤0.01% 382
2020
Q4
$496K Buy
14,190
+1,100
+8% +$38K ﹤0.01% 300
2020
Q3
$454K Buy
13,090
+3,042
+30% +$101K ﹤0.01% 291
2020
Q2
$329K Sell
10,048
-1,196
-11% -$38.2K ﹤0.01% 278
2020
Q1
$337K Sell
11,244
-1,214
-10% -$36.1K ﹤0.01% 276
2019
Q4
$361K Buy
12,458
+4,274
+52% +$118K ﹤0.01% 303
2019
Q3
$211K Buy
+8,184
New +$207K ﹤0.01% 345
2019
Q1
Sell
-11,966
Closed -$276K 338
2018
Q4
$276K Buy
+11,966
New +$266K ﹤0.01% 269

Other funds holding NVO